APA (7th ed.) Citation

Odintsova, S. V., Sviridenko, M. A., Cheremnykh, A. O., Filippova, E. A., Urtenova, M. A., & Orlov, S. V. (2020). Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma. IP Habib O.N.

Chicago Style (17th ed.) Citation

Odintsova, Svetlana V., Mariia A. Sviridenko, Antonina O. Cheremnykh, Elena A. Filippova, Magaripa A. Urtenova, and Sergei V. Orlov. Clinical Case of Long-term Use of Osimertinib in the Treatment of EGFR Mutation-positive Lung Adenocarcinoma. IP Habib O.N, 2020.

MLA (8th ed.) Citation

Odintsova, Svetlana V., et al. Clinical Case of Long-term Use of Osimertinib in the Treatment of EGFR Mutation-positive Lung Adenocarcinoma. IP Habib O.N, 2020.